血管内皮生长因子抑制剂辅助治疗肾细胞癌的新见解：到目前为止我们学到了什么？
New Insights into Adjuvant Renal Cell Carcinoma Treatment with Vascular Endothelial Growth Factor Inhibitors: What Have We Learned So Far?
机构信息
Gustave Roussy Cancer Institute, Villejuif Cedex, France.
Department of Urology, University of Munich, Klinikum Grosshadern, Munich, Germany.
出版信息
Eur Urol. 2018 Jan;73(1):1-3. doi: 10.1016/j.eururo.2017.08.020. Epub 2017 Sep 8.
PMID:28890247
Abstract
Adjuvant treatment of renal cell carcinoma with vascular endothelial growth factor inhibitors is feasible and effective with careful patient selection and standard dosing levels.
摘要
血管内皮生长因子抑制剂辅助治疗肾细胞癌是可行且有效的，但需要仔细选择患者并采用标准剂量水平。
Zotero 插件